📰 Presentation Title News
Page 9 - Presentation Title News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Presentation Title. Real-time updates on events, politics, business and more.
September 15, 2022
Aliso Viejo, CA (PRWEB) September 15, 2022 -- SpyGlass Pharma, a privately-held ophthalmic therapeutics company, today announced it will be unveiling a
July 8, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
June 9, 2022
RICHMOND, Va., June 9, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the acceptance of seven abstracts for presentation at the 84th Annual Scientific Meeting of the College on
June 8, 2022
/PRNewswire/ -- Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced that its...
June 7, 2022
06.06.2022 - - Company to host virtual investor event on Saturday, June 11 at 10:30 AM ET following its June 10th presentation of updated data from Phase 2 studies of bomedemstat for the treatment of Essential Thrombocythemia and Myelofibrosis at the 2022 ... Seite 1
June 6, 2022
- Company to host virtual investor event on Saturday, June 11 at 10:30 AM ET following its June 10th presentation of updated data from Phase 2 studies of...
May 26, 2022
All dose levels of Radspherin were well tolerated with a maximum dose level toxicity not reached in the RAD-18-002 study. Radspherin is currently being evaluated in two ongoing Phase 1 trials for
May 12, 2022
MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical
May 11, 2022
/PRNewswire/ -- LogicBio® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that it will present four abstracts...